A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring

The main objective of this article is to provide a comprehensive review of continuous glucose monitor (CGM) use in pregnant women with type 1 diabetes (T1D) from the CONCEPTT study including subanalyses. Literature search was accessed through MEDLINE (1966–September 2023) using the key terms: CONCEP...

Full description

Bibliographic Details
Main Authors: David Q Pham, Ashley Thorsell, Kristin Castorino, Brandon Cobb
Format: Article
Language:English
Published: Bioscientifica 2024-01-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/13/2/EC-23-0407.xml
_version_ 1827382724299587584
author David Q Pham
Ashley Thorsell
Kristin Castorino
Brandon Cobb
author_facet David Q Pham
Ashley Thorsell
Kristin Castorino
Brandon Cobb
author_sort David Q Pham
collection DOAJ
description The main objective of this article is to provide a comprehensive review of continuous glucose monitor (CGM) use in pregnant women with type 1 diabetes (T1D) from the CONCEPTT study including subanalyses. Literature search was accessed through MEDLINE (1966–September 2023) using the key terms: CONCEPTT, pregnancy, women, T1D, and CGM with limitations set to distinguish human subjects written in English. A total of 17 publications including one main clinical trial and 15 subanalyses have been published to date regarding the use of CGM in pregnant women with T1D which were conducted by a research group identified as the CONCEPTT Collaborative Group. While advances in maternal care have resulted in safer pregnancy for both the mother and child, women with preexisting T1D and pregnancy still experience higher rates of complications both in the short and long term. The use of CGM in pregnancy has not been studied extensively until more recently. The CONCEPTT clinical trial was a landmark study that involved several subanalyses. The main trial proved that CGM use in T1D pregnancy resulted in less hyperglycemia in the third trimester, reduced large for gestational age (LGA, >90th percentile), reduced neonatal intensive care unit admissions lasting longer than 24 h, and reduced neonatal hypoglycemia. Although subanalyses showed a variety of results including ‘inconclusive’ due to lack of prespecification, it is believed that CGM in T1D during pregnancy is to be recommended and used for overall improved outcomes.
first_indexed 2024-03-08T14:25:39Z
format Article
id doaj.art-e4e7f6eac79d467d9000d201d489d95c
institution Directory Open Access Journal
issn 2049-3614
language English
last_indexed 2024-03-08T14:25:39Z
publishDate 2024-01-01
publisher Bioscientifica
record_format Article
series Endocrine Connections
spelling doaj.art-e4e7f6eac79d467d9000d201d489d95c2024-01-13T05:59:41ZengBioscientificaEndocrine Connections2049-36142024-01-01131113https://doi.org/10.1530/EC-23-0407A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspringDavid Q Pham0Ashley Thorsell1Kristin Castorino2Brandon Cobb3Western University of Health Sciences, College of Pharmacy, Pomona, California, USA; Mary & Dick Allen Diabetes Center at Hoag Hospital, Newport Beach, California, USA Sansum Diabetes Research Institute, Santa Barbara, California, USASansum Diabetes Research Institute, Santa Barbara, California, USASansum Diabetes Research Institute, Santa Barbara, California, USAThe main objective of this article is to provide a comprehensive review of continuous glucose monitor (CGM) use in pregnant women with type 1 diabetes (T1D) from the CONCEPTT study including subanalyses. Literature search was accessed through MEDLINE (1966–September 2023) using the key terms: CONCEPTT, pregnancy, women, T1D, and CGM with limitations set to distinguish human subjects written in English. A total of 17 publications including one main clinical trial and 15 subanalyses have been published to date regarding the use of CGM in pregnant women with T1D which were conducted by a research group identified as the CONCEPTT Collaborative Group. While advances in maternal care have resulted in safer pregnancy for both the mother and child, women with preexisting T1D and pregnancy still experience higher rates of complications both in the short and long term. The use of CGM in pregnancy has not been studied extensively until more recently. The CONCEPTT clinical trial was a landmark study that involved several subanalyses. The main trial proved that CGM use in T1D pregnancy resulted in less hyperglycemia in the third trimester, reduced large for gestational age (LGA, >90th percentile), reduced neonatal intensive care unit admissions lasting longer than 24 h, and reduced neonatal hypoglycemia. Although subanalyses showed a variety of results including ‘inconclusive’ due to lack of prespecification, it is believed that CGM in T1D during pregnancy is to be recommended and used for overall improved outcomes.https://ec.bioscientifica.com/view/journals/ec/13/2/EC-23-0407.xmlpregnancycontinuous glucose monitortype 1 diabeteswomen
spellingShingle David Q Pham
Ashley Thorsell
Kristin Castorino
Brandon Cobb
A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring
Endocrine Connections
pregnancy
continuous glucose monitor
type 1 diabetes
women
title A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring
title_full A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring
title_fullStr A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring
title_full_unstemmed A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring
title_short A review of CONCEPTT study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring
title_sort review of conceptt study findings including subanalyses in pregnant women using continuous glucose monitoring with type 1 diabetes and their offspring
topic pregnancy
continuous glucose monitor
type 1 diabetes
women
url https://ec.bioscientifica.com/view/journals/ec/13/2/EC-23-0407.xml
work_keys_str_mv AT davidqpham areviewofconcepttstudyfindingsincludingsubanalysesinpregnantwomenusingcontinuousglucosemonitoringwithtype1diabetesandtheiroffspring
AT ashleythorsell areviewofconcepttstudyfindingsincludingsubanalysesinpregnantwomenusingcontinuousglucosemonitoringwithtype1diabetesandtheiroffspring
AT kristincastorino areviewofconcepttstudyfindingsincludingsubanalysesinpregnantwomenusingcontinuousglucosemonitoringwithtype1diabetesandtheiroffspring
AT brandoncobb areviewofconcepttstudyfindingsincludingsubanalysesinpregnantwomenusingcontinuousglucosemonitoringwithtype1diabetesandtheiroffspring
AT davidqpham reviewofconcepttstudyfindingsincludingsubanalysesinpregnantwomenusingcontinuousglucosemonitoringwithtype1diabetesandtheiroffspring
AT ashleythorsell reviewofconcepttstudyfindingsincludingsubanalysesinpregnantwomenusingcontinuousglucosemonitoringwithtype1diabetesandtheiroffspring
AT kristincastorino reviewofconcepttstudyfindingsincludingsubanalysesinpregnantwomenusingcontinuousglucosemonitoringwithtype1diabetesandtheiroffspring
AT brandoncobb reviewofconcepttstudyfindingsincludingsubanalysesinpregnantwomenusingcontinuousglucosemonitoringwithtype1diabetesandtheiroffspring